These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28467163)

  • 41. HIV-negative male couples' attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement.
    Mitchell JW; Lee JY; Woodyatt C; Bauermeister J; Sullivan P; Stephenson R
    AIDS Care; 2016 Aug; 28(8):994-9. PubMed ID: 27055001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High Interest in Syphilis Pre-exposure and Post-exposure Prophylaxis Among Gay, Bisexual and Other Men Who Have Sex With Men in Vancouver and Toronto.
    Fusca L; Hull M; Ross P; Grennan T; Burchell AN; Bayoumi AM; Tan DHS
    Sex Transm Dis; 2020 Apr; 47(4):224-231. PubMed ID: 31977974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HIV infection rate, high-risk behavior and pre-exposure prophylaxis/post-exposure prophylaxis in men who have sex with men in Beijing].
    Xia DY; Su XL; Liu GW; Ren XL; Wang J; Li GY; Chen J; Xu CH; Lu HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1390-1396. PubMed ID: 37743271
    [No Abstract]   [Full Text] [Related]  

  • 44. Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK--A Mixed Methods Study.
    Frankis J; Young I; Flowers P; McDaid L
    PLoS One; 2016; 11(4):e0151385. PubMed ID: 27093430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Qualitative Study of Medical Mistrust, Perceived Discrimination, and Risk Behavior Disclosure to Clinicians by U.S. Male Sex Workers and Other Men Who Have Sex with Men: Implications for Biomedical HIV Prevention.
    Underhill K; Morrow KM; Colleran C; Holcomb R; Calabrese SK; Operario D; Galárraga O; Mayer KH
    J Urban Health; 2015 Aug; 92(4):667-86. PubMed ID: 25930083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acceptance of pre-exposure prophylaxis and post-exposure prophylaxis against HIV and related factors in men who have sex with men in Shandong Province].
    Zhang XN; Yan K; You XD; Li JH; Zhang N; Wang GY; Liao MZ; Ma W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1352-1357. PubMed ID: 37743265
    [No Abstract]   [Full Text] [Related]  

  • 47. Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
    Kiptinness C; Naik P; Thuo N; Malen RC; Dettinger JC; Pintye J; Rafferty M; Jomo E; Nyamasyo N; Wood T; Isabelli P; Morris S; Hattery D; Stergachis A; Were D; Sharma M; Ngure K; Mugambi ML; Ortblad KF
    Front Public Health; 2023; 11():1054559. PubMed ID: 36908449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV postexposure prophylaxis in an urban population of female sex workers in Nairobi, Kenya.
    Izulla P; McKinnon LR; Munyao J; Karanja S; Koima W; Parmeres J; Kamuti S; Kioko R; Nagelkerke N; Gakii G; Wachihi C; Muraguri N; Musyoki H; Gelmon L; Kaul R; Kimani J
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):220-5. PubMed ID: 23111574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adoption of HIV pre-exposure prophylaxis among women at high risk of HIV infection in Kenya.
    Bien-Gund CH; Ochwal P; Marcus N; Bair EF; Napierala S; Maman S; Agot K; Thirumurthy H
    PLoS One; 2022; 17(9):e0273409. PubMed ID: 36084050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers to the uptake of postexposure prophylaxis among Nairobi-based female sex workers.
    Olsthoorn AV; Sivachandran N; Bogoch I; Kwantampora J; Kimani M; Kimani J; Kaul R
    AIDS; 2016 Jan; 30(1):99-103. PubMed ID: 26372489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey.
    Harling G; Muya A; Ortblad KF; Mashasi I; Dambach P; Ulenga N; Barnhart D; Mboggo E; Oldenburg CE; Bärnighausen T; Spiegelman D
    BMJ Open; 2019 Mar; 9(3):e023272. PubMed ID: 30898799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-exposure prophylaxis: an underutilized biomedical HIV prevention method among gay, bisexual and other men who have sex with men in China.
    Hou J; Wu Y; Xie L; Meng S; Fu R; Zheng H; He N; Huang X; Xu J; Meyers K
    AIDS Care; 2020 Dec; 32(12):1573-1580. PubMed ID: 32188267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of pre-exposure and post-exposure prophylaxes prevention programme on HIV burden and services in a low-resource setting: a simulation modelling approach.
    Adeoti AO; Demir E; Adeyemi S; Yakutcan U; Kengne AP; Kayode G; Aliyu A; Idika N; Isichei C
    Pan Afr Med J; 2021; 40():163. PubMed ID: 34970405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors Associated with Post-Exposure Prophylaxis Awareness Among Latino Sexual Minority Men in South Florida.
    Weinstein ER; Lozano A; Jones MA; Safren SA; Harkness A
    AIDS Patient Care STDS; 2022 Oct; 36(10):405-412. PubMed ID: 36286577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.